Gleevec
imatinib mesylate
- Strength
- 400 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Novartis Pharmaceuticals Corporation
imatinib mesylate
Listed by Upsher-Smith Laboratories, LLC
- Strength
- 400 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Imatinib Mesylate 400 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 0832-0533 |
| FDA application | ANDA212135 |
| RxNorm concept | 403878 |
| Package sizes listed | 1 |
| Marketed since | May 2024 |
Other products containing Imatinib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Gleevec
imatinib mesylate
- Strength
- 400 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Novartis Pharmaceuticals Corporation
Gleevec
imatinib mesylate
- Strength
- 100 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Novartis Pharmaceuticals Corporation
Imatinib
- Strength
- 100 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Dr.Reddy's Laboratories Inc
Imatinib
- Strength
- 400 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Dr.Reddy's Laboratories Inc
Imatinib Mesylate
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals USA, Inc.
Imatinib Mesylate
imatinib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Golden State Medical Supply, Inc.
imatinib mesylate
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
BluePoint Laboratories
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.